897
Participants
Start Date
August 27, 2020
Primary Completion Date
May 8, 2023
Study Completion Date
May 8, 2023
Dabigatran
Dabigatran
Cathay General Hospital, Taipei
Taipei Medical University Hospital, Taipei
Cheng Hsin General Hospital, Taipei
Taipei Medical University-Shuang Ho Hospital, New Taipei City
National Taiwan University Hospital-Hsin-Chu Branch, Hsinchu
Chang Gung Memorial Hospital(Linkou), Taoyuan District
Tungs' Taichung MetroHarbor Hospital, Taichung
Kuang-Tien General Hospital, Taichung
Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi City
NCKUH, Tainan City
Kaohsiung Municipal Da-Tung Hospital, Kaohsiung City
Pingtung Christian Hospital, Pingtung City
Buddhist Tzu Chi General Hospital, Hualien City
National Taiwan University Hospital, Taipei
Mackay Memorial Hospital, Taipei
Taipei Veterans General Hospital, Taipei
Tri-Service General Hospital, Taipei
Taipei Municipal Wanfang Hospital, Taipei
Chia-Yi Christian Hospital, Chia-Yi City
Taichung Veterans General Hospital, Taichung
Chi Mei Medical Center, Tainan City
Kaohsiung Veterans General Hospital, Kaohsiung City
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City
Lead Sponsor
Boehringer Ingelheim
INDUSTRY